AI Model Can Aid Physicians in Skin Cancer Diagnoses
By Lori Solomon HealthDay Reporter
TUESDAY, June 17, 2025 -- The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June 6 in Nature Medicine.
Siyuan Yan, from Monash University in Melbourne, Australia, and colleagues developed PanDerm, which was pretrained through self-supervised learning on more than 2 million real-world skin disease images from 11 clinical institutions across four imaging modalities. Then, PanDerm was evaluated using 28 diverse benchmarks, including skin cancer screening, risk stratification, differential diagnosis of common and rare skin conditions, lesion segmentation, longitudinal monitoring, and metastasis prediction and prognosis.
The researchers found that PanDerm's performance across all evaluated tasks was state-of-the-art, even outperforming existing models when using only 10 percent of labeled data. PanDerm outperformed clinicians by 10.2 percent in early-stage melanoma detection through a longitudinal analysis, improved clinicians' skin cancer diagnostic accuracy by 11 percent on dermoscopy images, and enhanced nondermatologist health care providers' differential diagnosis by 16.5 percent across 128 skin conditions on clinical photographs.
"Previous AI models have struggled to integrate and process various data types and imaging methods, reducing their usefulness to doctors in different real-world settings," co-lead author Zongyuan Ge, Ph.D., also from Monash University, said in a statement. "PanDerm is a tool designed to work alongside clinicians, helping them interpret complex imaging data and make informed decisions with more confidence."
Several authors disclosed ties to the pharmaceutical and biotechnology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Unfavorable Mental Health Outcomes Reported With THC Product Use
TUESDAY, Aug. 26, 2025 -- High-concentration delta-9-tetrahydrocannabinol (THC) cannabis products are associated with unfavorable mental health outcomes, according to a review...
New Guideline Developed for Management of High Blood Pressure
TUESDAY, Aug. 26, 2025 -- In a new 2025 joint guideline issued by the American Heart Association and the American College of Cardiology, published online Aug. 14 in Circulation...
Many Women Have Preexisting Modifiable Risk Factors for Birth Defects
TUESDAY, Aug. 26, 2025 -- About two-thirds of reproductive-aged women in the United States have preexisting modifiable risk factors for birth defects, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.